Balaji Amines (Mid Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Balaji Amines Limited |
|||
|
Price: ₹1,735.20 (-0.86%) | ||
| 52 Week Low: ₹1,677.45 52 Week High: ₹2,549.75 |
|||
| Market Capital: 6,429.81 Crore (Midcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Balaji Amines Share Price Target For 2025
- 1.1.1: Balaji Amines Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Balaji Amines Share Price Target For 2026
- 1.2.1: Balaji Amines Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Balaji Amines Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Balaji Amines Brief Company Overview
- 4: Balaji Amines Financial Performance
- 4.0.1: Is Balaji Amines A Good Buy For Long Term?
Balaji Amines, a Mid Cap company in the Specialty Chemicals Industry has delivered 359.2% returns in 5-year with 12.5% profit margin, making it a potential Multibagger.
To predict the Balaji Amines's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Balaji Amines Share Price Target For 2025
The line chart displays the monthly closing prices of Balaji Amines with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Balaji Amines shares in 2025, see the table below.
Balaji Amines Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1939.81 (+11.79%) | Technical Indicator: MA50 |
| 2025 Target 2 | 1915.04 (+10.36%) | Price Action: Mar 2023 Low |
| 2025 Target 1 | 1878.32 (+8.24%) | Price Action: Mar 2021 High |
| Current Price | 1735.20 | Balaji Amines's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1671.96 (-3.65%) | Price Action: Chart |
| Stop Loss 2 | 1655.24 (-4.61%) | Price Action: Chart |
| Stop Loss 3 | 1625.45 (-6.33%) | Price Action: Chart |
Short-Term Technical Outlook
Current Technical Position: Balaji Amines is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1823.44 serves as the nearest technical reference point.
Historical Returns: 3-month: -18.51% | 6-month: -30.59% | 1-year: -28.52%
Balaji Amines Share Price Target For 2026
The line chart displays the monthly closing prices of Balaji Amines with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Balaji Amines shares in 2026, see the table below.
Balaji Amines Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 2413.02 (+39.06%) | Price Action: 08 May 2024 High |
| 2026 Target 2 | 2386.29 (+37.52%) | Price Action: 26 Jun 2024 High |
| 2026 Target 1 | 2362.4 (+36.14%) | Price Action: 25 Jun 2024 High |
| Current Price | 1735.20 | Balaji Amines's share price as of 21 Jan 2025 |
| Stop Loss 1 | 1532.78 (-11.67%) | Price Action: Mar 2021 Low |
| Stop Loss 2 | 1517.45 (-12.55%) | Price Action: Chart |
| Stop Loss 3 | 1490.14 (-14.13%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Balaji Amines is currently trading near its 52-week low of ₹1677.45, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -28.52% | 3-year: -45.98% | 5-year: +359.24%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Balaji Amines Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,735.20 | ||
| 2025 | ₹2,108.05 | +21.48% | ₹2,139.67 |
| 2026 | ₹2,334.07 | +10.72% | ₹2,369.08 |
| 2027 | ₹2,614.53 | +12.01% | ₹2,653.75 |
| 2028 | ₹3,008.28 | +15.06% | ₹3,053.40 |
| 2029 | ₹3,624.36 | +20.47% | ₹3,678.73 |
| 2030 | ₹4,074.60 | +12.42% | ₹4,135.72 |
| 2031 | ₹4,527.31 | +11.11% | ₹4,595.22 |
| 2032 | ₹5,240.18 | +15.74% | ₹5,318.78 |
| 2033 | ₹6,155.26 | +17.46% | ₹6,247.59 |
| 2034 | ₹7,043.01 | +14.42% | ₹7,148.66 |
| 2035 | ₹7,634.07 | +8.39% | ₹7,748.58 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Balaji Amines Brief Company Overview
Balaji Amines Limited: A Leading Chemical and Hotel Enterprise Balaji Amines Limited is a prominent player in the manufacturing and distribution of specialty chemicals, pharma excipients, and methylamines and ethylamines in India. Established in 1988,...
Balaji Amines has built a formidable reputation in the chemical industry. The company's diverse product portfolio encompasses monomethylamine, dimethylamine, and specialty chemicals like N-methyl pyrrolidone and morpholine. Balaji Amines also manufactures pharma excipients such as poly vinyl pyrrolidone and derivatives like di-methyl acetamide. Beyond chemicals, the company operates a hotel, Balaji Sarovar Premiere, in Solapur, Maharashtra. Balaji Amines has a strong market presence, serving industries such as pharmaceuticals, agrochemicals, and water treatment chemicals. The company exports its products globally, reaching markets in the United States, the United Kingdom, and Latin America. Balaji Amines Limited is committed to delivering high-quality products and services to its customers, solidifying its position as a trusted partner in the industry.Balaji Amines Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 6,429.81 Crore | Market valuation of Balaji Amines's shares. |
| Revenue (TTM) | 1,562.58 Crore | Total revenue generated by Balaji Amines over the past twelve months. |
| Net Income (TTM) | +195.41 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +14.14% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +12.5% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-17% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-17.89% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
1.04 | Company's total debt divided by total shareholder equity. |
| Total Debt | 19.69 Crore | Sum of Balaji Amines's current & long-term financial obligations. |
| Total Cash | 330.61 Crore | Total amount of liquid funds available to Balaji Amines. |
| Beta | 1.19 | Beta is greater than 1 indicating that the Balaji Amines's price is more volatile than the market. |
Is Balaji Amines A Good Buy For Long Term?
Balaji Amines, a mid-cap stock with a market capitalization of ₹6,429.81 crore, shows mixed signals. While its ₹330.61 crore cash balance and relatively low debt (₹19.69 crore in Q2 2024-25) are positive, a significant decline in earnings (-17.9% YoY) and revenue (-17% QoQ) raises concerns. Although past 5-year returns are impressive (333.96%), recent performance is weak (-25.61% YTD). Considering this volatility, Balaji Amines is currently an average buy for long-term investors, requiring close monitoring of future performance.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
